MX2016008795A - Composiciones y métodos de tratamiento de afecciones inflamatorias de la piel, utilizando alantoína. - Google Patents

Composiciones y métodos de tratamiento de afecciones inflamatorias de la piel, utilizando alantoína.

Info

Publication number
MX2016008795A
MX2016008795A MX2016008795A MX2016008795A MX2016008795A MX 2016008795 A MX2016008795 A MX 2016008795A MX 2016008795 A MX2016008795 A MX 2016008795A MX 2016008795 A MX2016008795 A MX 2016008795A MX 2016008795 A MX2016008795 A MX 2016008795A
Authority
MX
Mexico
Prior art keywords
skin
ulcers
care
inflammatory
psoriasis
Prior art date
Application number
MX2016008795A
Other languages
English (en)
Inventor
Ryan Robert
Farber Elliott
Original Assignee
Scioderm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scioderm Inc filed Critical Scioderm Inc
Publication of MX2016008795A publication Critical patent/MX2016008795A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

Las realizaciones en este documento proporcionan formulaciones y métodos para el tratamiento de enfermedades inflamatorias de la piel utilizando alantoína en una cantidad desde aproximadamente 0.5% a aproximadamente 15.0% en peso. Las enfermedades inflamatorias de la piel tratadas por las realizaciones en este documento incluyen, sin limitación, porfiria cutánea, esclerodermia, epidermólisis bullosa, psoriasis, úlceras de decúbito, úlceras por presión, úlceras diabéticas, úlceras por estasis venosa, úlceras de células falciformes, úlceras causadas por quemaduras, eczema, urticaria, dermatitis atópica, dermatitis herpetiforme, dermatitis de contacto, artritis, gota, lupus eritematoso, acné, alopecia, carcinomas, psoriasis, rosácea, miliaria, infecciones de la piel, cuidado postoperatorio de incisiones, cuidado de la piel postoperatorio después de cualquier variedad de operaciones de cirugía plástica, cuidado de la piel después del tratamiento con radiación, cuidado de la piel seca, agrietada o envejecida o líneas de la piel, así como otras condiciones que afectan a la piel y que tienen un componente inflamatorio, síntomas de los mismos, o una combinación de los mismos. Los síntomas tratados pueden incluir dolor, inflamación, enrojecimiento, picazón, cicatrización, engrosamiento de la piel, acné miliar, o una combinación de los mismos.
MX2016008795A 2014-01-03 2014-01-03 Composiciones y métodos de tratamiento de afecciones inflamatorias de la piel, utilizando alantoína. MX2016008795A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/010248 WO2015102642A1 (en) 2014-01-03 2014-01-03 Allantoin compositions for treating inflammatory skin conditions

Publications (1)

Publication Number Publication Date
MX2016008795A true MX2016008795A (es) 2017-03-23

Family

ID=53493841

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008795A MX2016008795A (es) 2014-01-03 2014-01-03 Composiciones y métodos de tratamiento de afecciones inflamatorias de la piel, utilizando alantoína.

Country Status (7)

Country Link
EP (1) EP3089729A4 (es)
JP (1) JP2017502053A (es)
AU (1) AU2014374416A1 (es)
BR (1) BR112016015641A8 (es)
CA (1) CA2935836A1 (es)
MX (1) MX2016008795A (es)
WO (1) WO2015102642A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160338997A1 (en) * 2013-12-27 2016-11-24 Scioderm, Inc. Keloid reduction using topical allantoin
GB201607814D0 (en) 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
CN109091478A (zh) * 2017-06-20 2018-12-28 中国医学科学院药物研究所 尿囊素在制备抗高尿酸血症和抗痛风药物中的应用
CN116870157A (zh) * 2017-10-20 2023-10-13 日本乐敦制药株式会社 皮肤障碍改善用组合物
CN111773212A (zh) * 2020-08-14 2020-10-16 云南中医药大学 一种瑞香素的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94806A0 (en) * 1990-06-20 1991-04-15 Ernest Bar On Pharmaceutical preparation containing thiol derivatives together with other active compounds
US20060134149A1 (en) * 1999-07-23 2006-06-22 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US6281236B1 (en) * 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
DE102004020890A1 (de) * 2004-03-26 2005-10-13 Wolf, Wilhelm R. Salbe zur Behandlung von oder Prophylaxe vor Nagelbettentzündung
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
WO2012053009A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions comprising skin whitening agents
JP5769481B2 (ja) * 2011-04-15 2015-08-26 株式会社 資生堂 ウフェナマート含有皮膚外用剤
US20160338997A1 (en) * 2013-12-27 2016-11-24 Scioderm, Inc. Keloid reduction using topical allantoin

Also Published As

Publication number Publication date
JP2017502053A (ja) 2017-01-19
BR112016015641A2 (pt) 2017-10-03
CA2935836A1 (en) 2015-07-09
EP3089729A1 (en) 2016-11-09
EP3089729A4 (en) 2017-06-14
AU2014374416A1 (en) 2016-07-21
WO2015102642A1 (en) 2015-07-09
BR112016015641A8 (pt) 2017-10-10

Similar Documents

Publication Publication Date Title
MX2016008795A (es) Composiciones y métodos de tratamiento de afecciones inflamatorias de la piel, utilizando alantoína.
CA3006294A1 (en) Combinations of rapamycin and metformin for the treatment of joint and skin diseases
TR201903335T4 (tr) Biyolojik bir kontrol ajanı olarak clonostachys rosea izole suşunun kullanımı.
EA201991790A1 (ru) Терапевтические препараты апремиласта для местного применения
MA40076A (fr) Inhibiteurs de syk
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
MX2015016100A (es) Inhibidores de criopirina para prevenir y tratar la inflamacion.
RU2014150505A (ru) Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды
WO2015004609A3 (en) Adherent cells from placenta and use thereof in treatment of injured tendons
MX348024B (es) Compuestos de adamantilo.
MX2017000524A (es) Compuestos novedosos de pirimidina sustituida.
MX2020011016A (es) Composiciones para el tratamiento de condiciones de la piel.
TR201910955T4 (tr) Bakteriyofaj terapisi.
PH12017502221A1 (en) Use of benzimidazole derivatives for nocturnal acid breakthrough
MX2015013936A (es) Compuestos de pirimidina condensada sustituida.
RU2015112839A (ru) Составы, содержащие идебенон, n-ацетил-s-фарнезил-l-цистеин и эрготионеин, и их применение
MX2021010638A (es) Composicion para reducir la grasa local y el peso corporal y sustancias farmaceuticas y uso de las mismas.
BR112013010325A2 (pt) composições para o tratamento de úlceras periféricas de várias origens
MX2010009488A (es) Métodos para modular la actividad del receptor de mc5, y tratamiento de las afecciones relacionadas con este receptor.
MX2015015379A (es) Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos.
MX2013010308A (es) 2,4-pirimidindiaminas sustituidas para uso en lupus discoide.
WO2014070696A3 (en) Treatment of chronic dermal inflammatory with norketotifen
MY160377A (en) Topical pharmaceutical compositions
WO2014135622A3 (en) Treatment and prophylaxis of radiation dermatitis
BR112012021355A2 (pt) "material contendo silício biologicamente degradável para a terapia pró-angiogenética.